Response to Letter to Editor ‘increased cases of VGKC-complex observed during current COVID-19 pandemic’

We thank Vu et al. for their interest in our article published in 2018 in which we studied 50 anti-VGKC seropositive patients and compared individuals with either anti-LGI1 or anti-CASPR2 antibodies (n  = 7) to those without (n = 43) [1]. We found that a higher proportion of anti-LGI1/CASPR2 seropositive patients had limbic encephalitis, complex partial seizures, hippocampal imaging abnormalities, temporal epileptiform activity/electrographic seizures, tumours, and received acute and maint enance immunotherapy.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Source Type: research